Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-25 @ 1:20 PM
NCT ID:
NCT03051659
Group ID:
EG000
Title:
Eribulin Mesylate Combine With Pembrolizumab
Description:
* Pembrolizumab will be administered in clinic once per cycle, given 200mg/m\^2 intravenously prior to Eribulin Mesylate.
* Eribulin mesylate will be administered on Days 1 and 8 of each 21 day cycle for 1.4 mg/m\^2 intravenously.
Deaths Number Affected:
19
Deaths Number At Risk:
None
Serious Number Affected:
27
Serious Number At Risk:
44
Other Number Affected:
44
Other Number At Risk:
44
Study:
NCT03051659
Results Section:
NCT03051659
Adverse Events Module:
NCT03051659